Skip to main content
SpringerLink
Log in

Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Can Israel balance the rights of multinational drug companies with its own generic pharmaceutical industry?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Amendment to The Patents Law, 5727–1967 (1998 Amendment).

  2. See 35 USC 155, 155A, 156, 271(e); Proposed directive amending directive 2001/83/EC, Article 10.4.

  3. The Pharmacists Ordinance, New Version (1981). Laws of the state of Israel, State of Israel.

  4. US, Israeli officials to tackle dispute over drug data exclusivity. IP Law Bulletin (October 11, 2004).

  5. US, Israeli negotiators make progress in talks on drug IP rights. IP Law Bulletin (October 17, 2004).

  6. Intellectual property bill risks US censure. Jerusalem Post (September 9, 2004).

  7. Drugs vote Republican, which may be why the US is pressing Israel so hard on IP. Globes Online (September 26, 2004).

Download references

Author information

Authors and Affiliations

  1. Reinhold Cohn and Partners, PO Box 4060, Tel Aviv, 61040, Israel

    Tamar Morag-Sela & Ilan Cohn

  2. Merial Ltd.,, 3239 Satellite Blvd., Duluth, 30096-4640, Georgia, USA

    Judy Jarecki-Black

  3. D. Young & Co.,, 120 Holborn, London, EC1N 2DY, UK

    Zoe Clyde-Watson

Authors
  1. Tamar Morag-Sela
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilan Cohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas J Kowalski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Judy Jarecki-Black
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zoe Clyde-Watson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morag-Sela, T., Cohn, I., Kowalski, T. et al. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity. Nat Biotechnol 22, 1591–1592 (2004). https://doi.org/10.1038/nbt1204-1591

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1204-1591

  • Springer Nature America, Inc.

Search

Navigation